Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trialBruce E. Sands, Olga Fedorishina, Emese Mihály et al.|The Lancet|2022Cited by 295
Inulin fibre promotes microbiota-derived bile acids and type 2 inflammationMohammad Arifuzzaman, David Artis, Tae Hyung Won et al.|Nature|2022Cited by 214
Characterization of Genetic Loci That Affect Susceptibility to Inflammatory Bowel Diseases in African AmericansChengrui Huang, Anna Di Rienzo, Talin Haritunians et al.|Gastroenterology|2015Cited by 82
A Frameshift in CSF2RB Predominant Among Ashkenazi Jews Increases Risk for Crohn's Disease and Reduces Monocyte Signaling via GM-CSFLing-Shiang Chuang, Vincent Plagnol, Nicole Villaverde et al.|Gastroenterology|2016Cited by 67
Host metabolism balances microbial regulation of bile acid signallingTae Won, Frank C. Schroeder, Mohammad Arifuzzaman et al.|Nature|2025Cited by 62